Catalyst Wire Dossier Catalyst Wire Dossier

SG1002

· Sulfagenix Australia Pty Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SG1002, covering 2015-11-26 to 2020-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Assessing the Safety and Ability of SG1002 to Overcome Deficits in Hydrogen Sulfide in Heart Failure Patients [NA]

See pricing